Qui Tam and Whistleblower Litigation for Federal Contractors in Bethesda, Maryland
By Anthony I. Shin, Esq., Shin Law Office
BOTTOM LINE UP FRONT
If you work at a Bethesda federal contractor, an NIH grant program, or a Walter Reed or Defense Health Agency contract and have seen something at your employer that looks like fraud against the government, the decision about what to do next is one of the most consequential of your career. The False Claims Act lets you sue on behalf of the United States as a qui tam relator and share in any recovery. Section 3730(h) protects you from retaliation. Filing is irreversible once the seal goes on. Take a breath and read this before you do anything else.
I am Anthony Shin and I represent federal contractor and grantee employees who file in the District of Maryland. Call 571-445-6565 or use my contact page to Schedule a Consultation. The first call is protected by attorney-client privilege.
Why Bethesda FCA Cases Have Their Own Profile
Bethesda sits on top of one of the most concentrated federal medical and research footprints in the country. Walter Reed National Military Medical Center anchors the military side. The National Institutes of Health campus spans Rockville Pike, including the National Library of Medicine, the NIH Clinical Center, and the institutes. The Defense Health Agency’s contracting flow extends to Bethesda from its Falls Church headquarters. Lockheed Martin keeps its corporate headquarters here, and Marriott International keeps its global headquarters here. The major federal contractors (Leidos Biomedical, CACI, GDIT, Booz Allen, Battelle, ICF, Westat in nearby Rockville, MedImmune/AstraZeneca up in Gaithersburg) maintain Bethesda offices because the customer is here.
The Bethesda FCA picture is weighted toward medical, research, and grant-compliance fraud, alongside the conventional defense contractor patterns that Lockheed-style work brings. NIH grant fraud, DHA medical services contract fraud, Walter Reed contractor performance issues, Anti-Kickback Act violations in healthcare contracting, and cost mischarging on cost-plus medical research contracts all regularly appear. I work as an attorney near Bethesda with this exact workforce, on both qui tam matters and broader civil and employment litigation.
Local Federal Court Picture
Bethesda federal contractor and grantee qui tam cases are filed in the United States District Court for the District of Maryland, Greenbelt Division, which sits at 6500 Cherrywood Lane in Greenbelt. The Greenbelt Division covers Montgomery County and the broader DMV-Maryland geography. The District of Maryland does not have EDVA’s rocket docket, but cases still move on a defined schedule, and the Fourth Circuit precedent that governs FCA materiality, scienter, and qui tam procedure applies equally in both districts.
The Civil Division of the United States Attorney’s Office for the District of Maryland handles the DOJ investigation during the seal period. HHS Office of Inspector General, NIH Office of Management Assessment, DHA Inspector General, DOD IG, and the FBI’s health care fraud teams all participate as the underlying conduct touches their lanes. For Bethesda cases involving medical or research conduct, HHS OIG and NIH OMA participation is typically deep due to the customer relationship.
Common Bethesda Fraud Patterns
The patterns I see most often among the Bethesda workforce fall into three overlapping categories. First, medical and research grant compliance fraud: NIH grantees who certify compliance with grant terms while diverting funds, mischarging effort, or misrepresenting research conduct. Second, DHA and Walter Reed medical services contract fraud: contractors who bill for services not rendered, upcode procedures, or misrepresent staffing under TRICARE-adjacent contracts. Third, conventional defense contractor patterns from the Lockheed and DOD-adjacent workforce: defective pricing under 10 U.S.C. §3702, labor mischarging on cost-plus programs, false cybersecurity certifications under DFARS 252.204-7012 and NIST 800-171, and reverse false claims for unallowable costs under FAR Part 31.
The Anti-Kickback Act (41 U.S.C. §8702) deserves its own mention for the Bethesda medical workforce. Kickbacks in federal medical contracting trigger both AKA liability and FCA liability when the resulting claims are submitted for payment. Common patterns include sub-to-prime kickbacks, vendor-to-employee kickbacks, and consulting arrangements that disguise kickbacks. False cybersecurity certifications have become the most active enforcement area since the October 2021 launch of the DOJ Civil Cyber-Fraud Initiative, and DHA contracts handling protected health information are squarely within its framework.
How I Help
When a Bethesda federal contractor or grantee employee calls me about a potential qui tam case, my first conversation covers five points. The strength of the evidence. The materiality analysis under Escobar. The scienter analysis under SuperValu. The first-to-file risk under Section 3730(b)(5). And your professional and financial circumstances. The conversation usually lasts 1 to 2 hours and is protected by the attorney-client privilege. I do not commit to representation in the first meeting; I want to understand the case before either of us makes a commitment.
If the recommendation is qui tam filing, I prepare the complaint, the DOJ written disclosure statement, and the supporting documentation, file under seal in the District of Maryland, and coordinate with the DOJ during the investigation phase. NIH grant cases and DHA medical contracts often involve HIPAA-protected information; we handle these cases using lawful means that respect both HIPAA and the trade secret whistleblower immunity under 18 U.S.C. § 1833. If the recommendation is a Section 3730(h) retaliation claim alone, I prepare and file that. If the recommendation is internal reporting or external IG report without qui tam, I support you through that process.
Frequently Asked Questions
What if my work involves NIH grants or DHA medical contracts?
Great question, and the honest answer is that NIH grants and DHA medical contracts have their own evidentiary patterns but the underlying FCA framework is the same. NIH grant fraud cases run on certifications of compliance with the Notice of Award, the Grants Policy Statement, and effort reporting rules. DHA medical contract fraud cases run on billing accuracy, staffing compliance, and the AKA overlay. Both are FCA-actionable when the certifications are knowingly false and material to the government’s payment decision.
Are there special FCA issues for medical research and healthcare contractors?
Honest answer, yes. HIPAA protects patient information, and protected health information cannot be removed from approved systems even for whistleblower purposes. The Defend Trade Secrets Act whistleblower immunity at 18 U.S.C. §1833 protects disclosures to government officials or attorneys for legitimate whistleblower purposes, but it does not override HIPAA. We work the case by describing patterns rather than naming patients, coordinating with the DOJ and HHS OIG, and using lawful means throughout. NIH grant cases follow analogous patterns around research subject and grantee data.
How much can I recover as a Bethesda qui tam relator?
Fair question because the math matters. If the government intervenes and the case succeeds, you receive 15 to 25 percent of the recovery, plus attorney fees and costs. If the government declines and you proceed alone, 25-30%. Medical and research FCA recoveries have run from low six figures to the high eight or nine figures, depending on the size of the fraud and the number of claims. Per-claim penalty stacking under Section 3729(a)(1) drives recoveries up quickly when many invoices or grant draws are involved.
What if another worker already filed a qui tam on the same fraud?
Section 3730(b)(5) bars qui tam complaints based on the same essential facts already alleged in another pending case. Only the first relator to file can proceed. The seal makes prior filings invisible to you before you file. Counsel can run searches and analyses to assess this risk, though the seal limits certainty. NIH grant fraud cases, in particular, tend to attract multiple potential relators because grantee research groups are tight-knit and the misconduct often involves several team members.
Schedule a Consultation
I represent federal contractor and grantee employees in Bethesda, North Bethesda, Chevy Chase, Potomac, Rockville, and across the Montgomery County medical and research corridor who have seen fraud at their employer and are deciding what to do about it. Qui tam relator representation in the District of Maryland. Section 3730(h) retaliation defense. NDAA, SOX, and Dodd-Frank whistleblower claims. NIH and DHA matters. HIPAA-compliant handling. The first conversation is protected by attorney-client privilege and usually takes one to two hours.
Call 571-445-6565 or visit my contact page to Schedule a Consultation.
Related Guides
The sub-hub for this series:
The cornerstone hub for the full series:
Federal Contracting Law in Virginia and Maryland: A Northern Virginia Attorney’s Complete Guide
Companion clearance guide for the same workforce:
Security Clearance Defense for Federal Contractors in Bethesda, Maryland
References
10 U.S.C. §2409 (NDAA Whistleblower Protections for Defense Contractor Employees).
10 U.S.C. §3702 (Truthful Cost or Pricing Data Act).
18 U.S.C. §1833 (Defend Trade Secrets Act Whistleblower Immunity).
31 U.S.C. §3729 (False Claims Act Liability).
31 U.S.C. §3730 (False Claims Act Procedures, Qui Tam, Anti-Retaliation).
41 U.S.C. §8702 (Anti-Kickback Act).
Cochise Consultancy, Inc. v. United States ex rel. Hunt, 587 U.S. 262 (2019).
Department of Justice Civil Cyber-Fraud Initiative (October 2021).
Eberhardt v. Integrated Design and Construction, Inc., 167 F.3d 861 (4th Cir. 1999).
NIH Grants Policy Statement. https://grants.nih.gov
United States ex rel. Schutte v. SuperValu Inc., 598 U.S. 739 (2023).
Universal Health Services, Inc. v. United States ex rel. Escobar, 579 U.S. 176 (2016).
U.S. District Court for the District of Maryland. https://www.mdd.uscourts.gov
